Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis

The novel coronavirus SARS-CoV-2 disease “COVID-19” emerged in China and rapidly spread to other countries; due to its rapid worldwide spread, the WHO has declared this as a global emergency. As there is no specific treatment prescribed to treat COVID-19, the seeking of suitable therapeutics among e...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexpandi, Rajaiah, De Mesquita, Joelma Freire, Pandian, Shunmugiah Karutha, Ravi, Arumugam Veera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390959/
https://www.ncbi.nlm.nih.gov/pubmed/32793181
http://dx.doi.org/10.3389/fmicb.2020.01796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390959/
https://www.ncbi.nlm.nih.gov/pubmed/32793181
http://dx.doi.org/10.3389/fmicb.2020.01796

Ejemplares similares